Congenital Amegakaryocytic Thrombocytopenia
specificA rare, autosomal recessive inherited disorder caused by mutation in the c-Mpl gene. It is characterized by thrombocytopenia and absence of megakaryocytes. It presents with bleeding in the first month of life.
9
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Congenital Amegakaryocytic Thrombocytopenia(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 55.6 |
| 2 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive | 55.6 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 55.6 |
| 4 | NCI Comprehensive | 55.6 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 55.6 |
| 6 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 55.6 |
| 7 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 55.6 |
| 8 | Boston University Cancer CenterBoston, MA | 55.6 |
| 9 | University of Cincinnati Cancer CenterCincinnati, OH | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →